Clinical Trial Update: A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated the safety, tolerability, and pharmacokinetics of MTP-131 in subjects with congestive heart failure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• MTP-131 (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Congestive Heart Failure | Phase 1 | Status: COMPLETED